Patents by Inventor Ann-Kathrin Eisfeld

Ann-Kathrin Eisfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions using miR-3151 in the diagnosis and treatment of thyroid cancer
    Patent number: 9708612
    Abstract: Compositions comprising therapeutic oligonucleotide miR-3151 compounds that target the expression of genes associated with tumorigenesis or cell transformation are provided.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: July 18, 2017
    Assignee: The Ohio State University
    Inventors: Albert de la Chapelle, Ann-Kathrin Eisfeld
  • Methods and compositions using miR-3151 in the diagnosis and treatment of cancer
    Patent number: 9469852
    Abstract: Compositions comprising therapeutic oligonucleotide miR-3151 compounds that target the expression of genes associated with tumorigenesis or cell transformation are provided.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: October 18, 2016
    Assignee: The Ohio State University
    Inventors: Albert de la Chapelle, Ann-Kathrin Eisfeld
  • Methods and Compositions using miR-3151 in the Diagnosis and Treatment of Thyroid Cancer
    Publication number: 20160168566
    Abstract: Compositions comprising therapeutic oligonucleotide miR-3151 compounds that target the expression of genes associated with tumorigenesis or cell transformation are provided.
    Type: Application
    Filed: February 12, 2016
    Publication date: June 16, 2016
    Applicant: The Ohio State University
    Inventors: Albert de la Chapelle, Ann-Kathrin Eisfeld
  • Methods and Compositions Using miR-3151 in the Diagnosis and Treatment of Cancer
    Publication number: 20150225721
    Abstract: Compositions comprising therapeutic oligonucleotide miR-3151 compounds that target the expression of genes associated with tumorigenesis or cell transformation are provided.
    Type: Application
    Filed: April 24, 2015
    Publication date: August 13, 2015
    Applicant: THE OHIO STATE UNIVERSITY
    Inventors: Albert de la Chapelle, Ann-Kathrin Eisfeld
  • Methods and compositions using miR-3151 in the diagnosis and treatment of cancer
    Patent number: 9057068
    Abstract: Compositions comprising therapeutic oligonucleotide compounds that target the expression of genes associated with tumorigenesis or cell transformation are provided. Methods are described to manipulate and treat the oncogenic deregulation of the TP53-associated apoptosis pathway. Markers for acute myeloid leukemia (AML) and uses thereof are described.
    Type: Grant
    Filed: April 1, 2013
    Date of Patent: June 16, 2015
    Assignee: The Ohio State University
    Inventors: Albert de la Chapelle, Ann-Kathrin Eisfeld